BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21887456)

  • 21. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
    Singh T; Katiyar SK
    Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Honokiol protects rats against eccentric exercise-induced skeletal muscle damage by inhibiting NF-kappaB induced oxidative stress and inflammation.
    Chiang J; Shen YC; Wang YH; Hou YC; Chen CC; Liao JF; Yu MC; Juan CW; Liou KT
    Eur J Pharmacol; 2009 May; 610(1-3):119-27. PubMed ID: 19303869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnolia ovovata extract and its active component magnolol prevent skin photoaging via inhibition of nuclear factor kappaB.
    Tanaka K; Hasegawa J; Asamitsu K; Okamoto T
    Eur J Pharmacol; 2007 Jun; 565(1-3):212-9. PubMed ID: 17346696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling.
    Lee J; Jung E; Park J; Jung K; Lee S; Hong S; Park J; Park E; Kim J; Park S; Park D
    Planta Med; 2005 Apr; 71(4):338-43. PubMed ID: 15856410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cistanche deserticola extract increases bone formation in osteoblasts.
    Li TM; Huang HC; Su CM; Ho TY; Wu CM; Chen WC; Fong YC; Tang CH
    J Pharm Pharmacol; 2012 Jun; 64(6):897-907. PubMed ID: 22571269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of NF-κB activation by gentian violet promotes osteoblastogenesis and suppresses osteoclastogenesis.
    Yamaguchi M; Vikulina T; Arbiser JL; Weitzmann MN
    Curr Mol Med; 2014; 14(6):783-92. PubMed ID: 25056540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.
    Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H
    Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation.
    Yamaguchi M; Weitzmann MN; Murata T
    Mol Cell Biochem; 2012 Jan; 359(1-2):193-203. PubMed ID: 21842421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.
    Yamaguchi M; Weitzmann MN
    Mol Cell Biochem; 2011 Sep; 355(1-2):179-86. PubMed ID: 21533765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Honokiol suppresses TNF-α-induced migration and matrix metalloproteinase expression by blocking NF-κB activation via the ERK signaling pathway in rat aortic smooth muscle cells.
    Zhu X; Wang Z; Hu C; Li Z; Hu J
    Acta Histochem; 2014 May; 116(4):588-95. PubMed ID: 24360976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
    Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
    Ichikawa H; Murakami A; Aggarwal BB
    Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative inhibitory effects of magnolol, honokiol, eugenol and bis-eugenol on cyclooxygenase-2 expression and nuclear factor-kappa B activation in RAW264.7 macrophage-like cells stimulated with fimbriae of Porphyromonas gingivalis.
    Murakami Y; Kawata A; Seki Y; Koh T; Yuhara K; Maruyama T; Machino M; Ito S; Kadoma Y; Fujisawa S
    In Vivo; 2012; 26(6):941-50. PubMed ID: 23160676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha.
    Li W; Yu B; Li M; Sun D; Hu Y; Zhao M; Cui CB; Hou S
    Biochem Biophys Res Commun; 2010 Jan; 391(2):1228-33. PubMed ID: 20006586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells.
    Hoi CP; Ho YP; Baum L; Chow AH
    Phytother Res; 2010 Oct; 24(10):1538-42. PubMed ID: 20878707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights on the Multifunctional Activities of Magnolol.
    Zhang J; Chen Z; Huang X; Shi W; Zhang R; Chen M; Huang H; Wu L
    Biomed Res Int; 2019; 2019():1847130. PubMed ID: 31240205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.